Dear Doctor Letter

Also found in: Acronyms.
A remedial communication required by the FDA when a drug company advertises a drug with incomplete/misleading information about its efficacy/safety
References in periodicals archive ?
This Petition Clause analysis was uncontested before the Court and is unrelated to the validity under the Free Speech Clause of the FDA's interpretation of its Dear Doctor letter regulations.
Finally, and critically for purposes of this Comment, the plaintiffs mounted a separate argument: that the generic manufacturers could have employed so-called Dear Doctor letters (28) to "send additional warnings to prescribing physicians.
Indeed, the plaintiffs' merits brief did not once refer to the regulation that, in the FDA's view, brought Dear Doctor letters under the "labeling" regulatory regime.
If the First Amendment forbids the FDA's interpretation regarding Dear Doctor letters, a more principled route for recovery exists.
Well, it's back (although sadly not in magazine form, so you'll have to send your Dear Doctor letters elsewhere).